The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer-Reference-Cited by-同舟云学术

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer

Published:2019-07-11 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Yasinska Inna M.,Sakhnevych Svetlana S.,Pavlova Ludmila,Teo Hansen Selnø Anette,Teuscher Abeleira Ana Maria,Benlaouer Ouafa,Gonçalves Silva Isabel,Mosimann Marianne,Varani Luca,Bardelli Marco,Hussain Rohanah,Siligardi Giuliano,Cholewa Dietmar,Berger Steffen M.,Gibbs Bernhard F.,Ushkaryov Yuri A.,Fasler-Kan Elizaveta,Klenova Elena,Sumbayev Vadim V.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference35 articles.

1. Unlocking the therapeutic potential of primary tumor-draining lymph nodes;Rotman;Cancer Immunol Immunother.,2019

2. The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells;Gonçalves Silva;EBioMed.,2017

3. Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression;Sakhnevych;Cell Mol Immunol.,2018

4. The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukaemia cells;Gonçalves Silva;OncoImmunology.,2016

5. The role of galectins in protein trafficking;Delacour;Traffic.,2009

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latrophilin-3 as a downstream effector of the androgen receptor induces bladder cancer progression;Discover Oncology;2024-09-13

2. Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape;Frontiers in Immunology;2024-09-13

3. Advances in immunotherapy for breast cancer and feline mammary carcinoma: From molecular basis to novel therapeutic targets;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer;Cancer Medicine;2024-09

5. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors;OncoImmunology;2024-07-18